Literature DB >> 7699584

Frequency response method in pharmacokinetics.

L Dedík1, M Durisová.   

Abstract

The paper presents the demonstration of applicability of the frequency response method in a bioavailability study. The frequency response method, common in system engineering, is based on an approximation of the frequency response of a linear dynamic system, calculated from input-output measurements, by a frequency model of the system transfer function in the frequency domain. In general, the influence of the system structure on the form of the system frequency response is much more distinct than on the form of the system output. This is of great advantage in modeling the system frequency response instead of the system output, commonly used in pharmacokinetics. After a brief theoretical section, the method is demonstrated on the estimation of the rate and extent of gentamicin bioavailability after intratracheal administration to guinea pigs. The optimal frequency model of the system describing the gentamicin pathway into the systemic circulation and point estimates of its parameters were selected by the approximation of the system frequency response in the frequency domain, using a noniterative algorithm. Two similar estimates of the system weighing function were independently obtained: the weighting function of the selected frequency model and the weighting function estimated by the numerical deconvolution procedure. Neither of the estimates of the weighting function does decrease monotonously after the maximum of about 2.2-2.5 unit of dose hr-1 recorded approximately 0.1 hr after drug administration. Both estimates show a marked additional peak approximately at 0.3 hr after administration and possible peaks in the further time period. We hypothesized that the loop found in the frequency response calculated and in the selected optimal frequency model, the high-order of this model, and several peaks identified in the estimates of the system weighting function indicated the complexity of the system and the presence of time delays. Three estimates of the extent of gentamicin intratracheal bioavailability obtained by the three different ways: directly from the calculated frequency response, calculated using the selected frequency model, and by the deconvolution method were 0.950, 0.934, and 0.907 respectively. Thus the conclusion can be made that gentamicin injected intratracheally to guinea pigs is almost completely available.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7699584     DOI: 10.1007/bf02353623

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  8 in total

1.  Do you need a pharmacokinetic model, and, if so, which one?

Authors:  J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1975-12

2.  Dynamic linearity of VO2 responses during aerobic exercise.

Authors:  U Hoffmann; D Essfeld; H G Wunderlich; J Stegemann
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1992

3.  Dynamic behaviour of alpha-motoneurons subjected to recurrent inhibition and reflex feedback via muscle spindles.

Authors:  U Windhorst; T Kokkoroyiannis
Journal:  Neuroscience       Date:  1992       Impact factor: 3.590

4.  Quantitative effects of sympathetic and vagal nerve stimulations on sinus and AV junctional rhythms.

Authors:  B H Neely; F Urthaler
Journal:  J Auton Nerv Syst       Date:  1992-02

5.  Pharmacokinetics from a dynamical systems point of view.

Authors:  J M van Rossum; J E de Bie; G van Lingen; H W Teeuwen
Journal:  J Pharmacokinet Biopharm       Date:  1989-06

6.  A note on appropriate constraints on the initial input response when applying deconvolution.

Authors:  P Veng-Pedersen; W R Gillespie
Journal:  J Pharmacokinet Biopharm       Date:  1986-08

7.  Pitfalls and valid approaches to pharmacokinetic analysis of mean concentration data following intravenous administration.

Authors:  D M Cocchetto; W A Wargin; J W Crow
Journal:  J Pharmacokinet Biopharm       Date:  1980-12

8.  Pharmacokinetics of gentamicin administered intratracheally or as an inhalation aerosol to guinea pigs.

Authors:  T Trnovec; M Durisová; S Bezek; Z Kállay; J Navarová; O Tomcíková; M Kettner; F Faltus; M Erichleb
Journal:  Drug Metab Dispos       Date:  1984 Sep-Oct       Impact factor: 3.922

  8 in total
  7 in total

1.  Sensitivity analysis of pharmacokinetic and pharmacodynamic systems: I. A structural approach to sensitivity analysis of physiologically based pharmacokinetic models.

Authors:  I A Nestorov
Journal:  J Pharmacokinet Biopharm       Date:  1999-12

2.  Classical Michaelis-Menten and system theory approach to modeling metabolite formation kinetics.

Authors:  Jovan Popović
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2004 Jul-Sep       Impact factor: 2.441

3.  Spline functions in convolutional modeling of verapamil bioavailability and bioequivalence. I: conceptual and numerical issues.

Authors:  J Popović
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2006 Apr-Jun       Impact factor: 2.441

4.  Lumping of whole-body physiologically based pharmacokinetic models.

Authors:  I A Nestorov; L J Aarons; P A Arundel; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1998-02

5.  Modeling in frequency domain used for assessment of in vivo dissolution profile.

Authors:  M Durisová; L Dedík
Journal:  Pharm Res       Date:  1997-07       Impact factor: 4.200

6.  Building a structured model of a complex pharmacokinetic system with time delays.

Authors:  M Durisová; L Dedík; M Balan
Journal:  Bull Math Biol       Date:  1995-11       Impact factor: 1.758

7.  A system-approach method for the adjustment of time-varying continuous drug infusion in individual patients: a simulation study.

Authors:  Mária Durisová; Ladislav Dedík
Journal:  J Pharmacokinet Pharmacodyn       Date:  2002-12       Impact factor: 2.745

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.